A novel clinical risk score that can accurately predict recurrence of craniopharyngioma - a multicentre cohort study

Nikolina Kyprianou, Carles Gaston‐Massuet(Queen Mary University of London), Tanja Škorić, Antonio Mario Bulfamante(Ospedale dei Bambini Vittore Buzzi), Kanna Gnanalingham, Jorge Torales, Valentina Massa(University of Milan), Danda Pani, Bassel Zebian(King's College London), Gaetano Bulfamante(University of Milan), Ashutosh Rai, Dimitrios Paraskevopoulos, Susan M. Webb(Universitat Autònoma de Barcelona), Teresa Ribalta, Prakamya Gupta, Nicolàs Samprón, Amar Ahmad(Cancer Research UK), Gevers Evelien F Pease, Pinaki Dutta(Post Graduate Institute of Medical Education and Research), Anil Bhansali(Trinity Health), Mehul Dattani(Great Ormond Street Hospital), Federico Roncaroli(Manchester Academic Health Science Centre), Eugenia Resmini(Hospital Universitari Germans Trias i Pujol), Nicolas Goycoolea, Betina Biagetti(Vall d'Hebron Institut de Recerca), Jesús Argente(Madrid Institute for Advanced Studies), James Blackburn, Rachael Tan, Darko Kaštelan(University Hospital Centre Zagreb), R. Mitchell, N. Thomas(International Space Science Institute), Cristina Preda(Grigore T. Popa University of Medicine and Pharmacy), Pravin Salunke, Jane Evanson(Barts Health NHS Trust), Laura Audı́, Ritika R. Kapoor, Christopher Chandler(University Hospitals Sussex NHS Foundation Trust), Márta Korbonits(Queen Mary University of London)

59th ESPE Annual Meeting (ESPE 2021 Online)

January 1, 2021

Cited by 0

|Cancer Cell|2017|1.3k

|Nature|2005|585

|Journal of Biological Chemistry|2005|469

|Endocrine Reviews|2009|466

|Endocrine Related Cancer|2017|357

Related Papers